119 results on '"Schorge, J.O."'
Search Results
2. A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer
3. Intraperitoneal chemotherapy improves oncologic outcome in stage IIIC epithelial ovarian cancer patients with miliary subtype
4. Risk of unplanned postoperative readmission after sentinel lymph node biopsy compared to complete inguinofemoral lymphadenectomy in patients with squamous cell carcinoma of the vulva
5. Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option?
6. A comparison of sentinel lymph node biopsy to lymphadenectomy for high-grade endometrial cancer staging
7. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer
8. Adjuvant chemotherapy and radiotherapy compared with radiotherapy alone in women with early-stage high-risk endometrial cancer: Analysis of the National Cancer Data Base
9. Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer
10. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis
11. Laparoscopic interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer
12. Does histologic subtype affect the risk of lymph node metastasis in apparent stage I epithelial ovarian cancer?
13. Minimally invasive staging surgery in women with early-stage endometrial cancer: Analysis of the National Cancer Data Base
14. Associations between residual disease and overall survival among histologic subtypes of epithelial ovarian cancer
15. Aborted upfront debulking does not reduce likelihood of optimal interval debulking compared with planned neoadjvuant chemotherapy
16. Fertility-conserving surgery among young women with stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base
17. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
18. Trends in the use of neoadjuvant chemotherapy for advanced-stage ovarian cancer: A National Cancer Data Base study
19. Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base
20. Staging lymphadenectomy in low-grade endometrial cancer: A prospective cohort study utilizing a standard algorithm
21. Outcomes among patients with advanced-stage low-grade serous ovarian cancer: Analysis of the National Cancer Data Base, 2003-2011
22. Patient, treatment, and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
23. Racial disparities in survival in malignant germ cell tumors of the ovary
24. Management of type II/high-grade endometrial cancer: A prospective cohort study utilizing a standard algorithm
25. Staging Lymphadenectomy in Low Grade Endometrial Cancer: A Prospective Cohort Study Utilizing a Standard Algorithm
26. Patterns of Care, Predictors and Outcomes of Chemotherapy for Uterine Serous Carcinoma: A population-based analysis
27. Patient, Treatment and Discharge Factors associated with Hospital Readmission within 30days after Surgery for Vulvar Cancer
28. Abstract 13: Trends in treatment of uterine serous cancer in the medicare population
29. Trends in treatment of uterine serous cancer in the Medicare population
30. Recent trends in the utilization of lymphadenectomy among patients undergoing surgery for endometrioid adenocarcinoma of the endometrium: An analysis of the Surveillance, Epidemiology, and End Results database, 1998–2010
31. Impact of venous thromboembolism on mortality of elderly Medicare patients with epithelial endometrial cancer
32. Racial disparities in treatment of high grade endometrial cancer in the Medicare population
33. Trends in the treatment of uterine leiomyosarcoma in the Medicare population
34. The impact of adjuvant therapy on survival in uterine clear cell carcinoma patients
35. Gynecologic oncologist as surgical consultant: Intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training
36. The impact of body mass index on intraperitoneal chemotherapy outcomes
37. Dual HER2 targeting impedes growth of HER2 gene-amplified uterine papillary serous carcinoma xenografts
38. Risk of second primary breast cancer among women with epithelial ovarian cancer compared to fallopian tube cancer
39. Distribution of ovarian cancer recurrence following intravenous (IV) and intraperitoneal (IP) adjuvant chemotherapy after upfront cytoreductive surgery
40. Prognostic factors of lymph node involvement in endometrioid endometrial cancer: A SEER analysis
41. Primary debulking surgery or neoadjuvant chemotherapy: What is the optimal treatment approach for obese patients with ovarian/fallopian tube/primary peritoneal carcinoma?
42. Management and outcomes for elderly women with vulvar cancer over time
43. Primary debulking surgery in stage IIIC and IV ovarian cancer results in improved survival compared to those undergoing neoadjuvant chemotherapy with interval cytoreduction
44. Management of advanced epithelial ovarian cancer in the elderly
45. Patient, treatment, and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer
46. Why Not Do LESS? Laparoendoscopic Single-Site Surgery Versus Traditional Multiport Laparoscopy for Surgical Management of the Adnexal Mass
47. Preserving the Rectus: Laparoendoscopic Single-Site Surgery Versus Traditional Multiport Laparoscopy for Prophylactic Salpingo-Oophorectomy
48. Patient, Treatment and Discharge Factors associated with Hospital Readmission within 30 days after Surgery for Vulvar Cancer
49. Laparoscopic Staging of Endometrial Cancer: Should We Even Bother Training Fellows without a Robot?
50. Trends in treatment of uterine serous cancer in the Medicare population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.